Ventilation inhomogeneity in α1-antitrypsin-deficient emphysema

European Respiratory Journal

Volumn 28, Issue 2, 2006, Pages 323-329

  Fregonese, L ^a   Van Veen, H P A A ^a   Sterk, P J ^a   Stolk, J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

1 Antitrypsin deficiency; Cigarette smoking; Diffusion capacity; Emphysema; Single breath nitrogen wash out test; Small airways

Indexed keywords

BRONCHODILATING AGENT; CARBON MONOXIDE; CORTICOSTEROID DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; ALPHA 1 ANTITRYPSIN; NITROGEN;

ADULT; AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BRONCHODILATATION; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE COURSE; FEMALE; GAS DIFFUSION; HUMAN; LUNG EMPHYSEMA; LUNG FLOW VOLUME CURVE; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY ANALYSIS; SINGLE BREATH NITROGEN TEST; SPIROMETRY; BREATH ANALYSIS; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; GENETIC DISORDER; GENETICS; LUNG; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; ALPHA 1-ANTITRYPSIN; BREATH TESTS; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC DISEASES, INBORN; HUMANS; LUNG; MALE; MIDDLE AGED; NITROGEN; PULMONARY EMPHYSEMA;

EID: 33845483126     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00122505     Document Type: Article

References (38)

1. Pauwels A, Buist S, Calverley PMA, Jenkins CR, Hurd SS, on behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
2. Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
3. Demedts M, Cosemans J, De Roo M, Billiet L, van de Woesteijne KP. Emphysema with minor airway obstruction and abnormal tests of small airway disease. Respiration 1978; 35: 148-157.
4. American Thoracic Society/European Respiratory Society Statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168: 818-900.
5. McElvaney NG, Crystal RD.: Clinical manifestations of alpha-1-antitrypsin deficiency. In: Crystal RG, ed. Lung Biology in Health and Disease. Vol. 88: Alpha-1 Antitrypsin Deficiency. 1st Edn. Marcel Dekker, New York, 1996; pp. 227-245.
6. Wilson JS, Galvin JR. Normal diffusing capacity in patients with PiZ alpha-1 antitrypsin deficiency, severe airflow obstruction, and significant radiographic emphysema. Chest 2000; 118: 867-871.
7. Parr DG, Stoel BC, Stolk J, Stockley RA. Pattern of emphysema distribution in alpha-1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med 2004; 170: 1172-1178.
8. MacNee W, Gould G, Lamb D. Quantifying emphysema by CT scanning. Clinicopathologic correlates. Ann NY Acad Sci 1991; 624: 179-194.
9. Johnson DC. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. Respir Med 2000; 94: 28-37.
10. MacIntyre N, Crapo RO, Viegi G, et al. Standardisation of lung function testing. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735.
11. Watson A, Joyce H, Pride NB. Changes in carbon monoxide transfer over 22 years in middle-aged men. Respir Med 2000; 94: 1103-1108.
12. Sterk PJ, Quanjer PH, van Zomeren BC, Wise ME, van der Lende R. The single breath nitrogen test in epidemiological surveys: an appraisal. Bull Eur Physiopathol Respir 1981; 17: 381-397.
13. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary function tests. N Engl J Med 1978; 298: 1277-1281.
14. Stanescu D, Sanna A, Veriter C, Robert A. Identification of smokers susceptible to development of chronic airflow limitation: a 13 year follow-up. Chest 1998; 114: 416-425.
15. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653.
16. Willems LN, Kramps JA, Stijnen T, Sterk PJ, Weening JJ, Dijkman JH. Relation between small airways disease and parenchymal destruction in surgical lung specimens. Thorax 1990; 45: 89-94.
17. Tomashefski JF, Crystal RG, Wiedemann HP, Mascha E, Stoller JK, Alpha-1 Antitrypsin Deficiency Registry Study Group. The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the national registry for individuals with severe deficiency of alpha-1 antitrypsin. Hum Pathol 2004; 35: 1452-1461.
18. Kim WD, Eidelman DH, Izquierdo JL, Ghezzo H, Saetta MP, Cosio GM. Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities. Am Rev Respir Dis 1991; 144: 1385-1390.
19. European Respiratory Society. Standardised lung function testing. Eur Respir J 1993; 6: Suppl. 16, 16-58.
20. Battaglia S, den Hertog H, Timmers MC, et al. Small airways function and molecular markers in exhaled air in mild asthma. Thorax 2005; 60: 639-644.
21. In't Veen JC, Beekman AJ, Bel EH, Sterk PJ. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 2000; 161: 1902-1906.
22. Buist AS, Ross BB. Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. Am Rev Respir Dis 1973; 108: 1078-1084.
23. Stanescu DC, Rodenstein DO, Hoeven C, Robert A. "Sensitive tests" are poor predictors of the decline in forced expiratory volume in one second in middle-aged smokers. Am Rev Respir Dis 1987; 135: 585-590.
24. 2 test identify the smoker who will develop chronic airflow limitation? Am Rev Respir Dis 1988; 137: 293-301.
25. Verbanck S, Schuermans D, Meysman M, Paiva M, Vincken W. Noninvasive assessment of airway alterations in smokers: the small airways revisited. Am J Respir Crit Care Med 2004; 170: 414-419.
26. Verbanck S, Schuermans D, Van Muylem A, et al. Conductive and acinar lung-zone contributions to ventilation inhomogeneity in COPD, 1998; 157: 1573-1577.
27. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-721.
28. Rubio ML, Sanchez-Cifuentes MV, Peces-barba G, Verbanck S, Paiva M, Gonzalez Mangado N. Intrapulmonary gas mixing in panacinar-and centriacinar-induced emphysema in rats. Am J Respir Crit Care Med 1998; 157: 237-245.
29. Saetta M, Kim WD, Izquierdo JL, Ghezzo H, Cosio MG. Extent of centrilobular and panacinar emphysema in smokers's lungs: pathological and mechanical implications. Eur Respir J 1994; 7: 664-671.
30. Eidelman DH, Ghezzo H, Kim WD, Hyatt RE, Cosio MG. Pressure-volume curves in smokers. Comparison with alpha-1-antitrypsin deficiency. Am Rev Respir Dis 1989; 139: 1452-1458.
31. Otis AB, McKerrow CB, Bartlett RA, et al. Mechanical factors in distribution of pulmonary ventilation. J Appl Physiol 1956; 8: 427-443.
32. Cheung D, Schot R, Zwinderman AH, Zagers H, Dijkman JH, Sterk PJ. Relationship between loss in parenchymal elastic recoil pressure and maximal airway narrowing in subjects with alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 1997; 155: 135-140.
33. Anthonisen NR, Robertsen PC, Ross WRD. Gravity-dependent sequential emptying of lung regions. J Appl Physiol 1970; 28: 589-594.
34. Berend N, Glanville AR, Grunstein MM. Determinants of the slope of phase III of the single breath nitrogen test. Bull Eur Physiopathol Resp 1984; 20: 512-517.
35. Sherril DL, Enright PL, Kalterborn WT, Lebowitz MD. Predictors of longitudinal change in diffusing capacity over 8 years. Am J respir Crit Care Med 1999; 160: 1883-1887.
36. DeMeo DL, Silverman EK. α1-Antitrypsin deficiency. 2: genetic aspects of α1-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 2004; 59: 259-264.
37. Piitulainen E, Eriksson S. Decline in FEV1 related to smoking status in individuals with severe a-1 antitrypsin deficiency (PiZZ). Eur Respir J 1999; 13: 247-251.
38. Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha1-antitrypsin deficiency (PiZZ). Thorax 1997; 52: 244-248.